J-Star Research

Porton logo and rainbow graphic with Chinese text. Caption reads: "The attendance of four hopeful DMD families from Chongqing is sponsored by.

Keep hope alive! We invite you to stay tuned to DMD

blank
blank

From September 6 to 7 2024, the Porton Wecare Program accompanied the families of four Chongqing DMD patients to Shanghai to participate in the 13th China Rare Disease Summit 2024.

The summit, co-sponsored by the Chinese Organization for Rare Disorders …

Banner for the 5th Pharma Crystallization Summit, featuring Industry Elites, on Sept. 26-27, 2024, at Crowne Plaza Princeton, NJ. Focused on debottlenecking drug development with insights from leading experts and Porton specialists.

Join Porton and Industry Elites at Pharma Crystallization Summit 2024!

Pharma Crystallization Summit 2024: Join Industry Leaders and Porton

As a proud gold sponsor of the Pharma Crystallization Summit 2024 (PCS 2024), the Crystallization Team at Porton, with locations in New Jersey (USA) and Shanghai (China), offers expert services …

Join us at CPHI Europe 2024 in Fiera Milano, Italy, from October 8-10. Visit Porton at Booth 5C17 against the backdrop of a stunning aerial view of a cathedral.

Connect with Porton at CPhI Europe 2024 @ Booth 5C17

CPhI Europe (October 8-10) in Milan, Italy, stands as a worldwide event in the pharmaceutical industry, bringing together key players, thought leaders, and businesses from across the globe. At this year’s exhibition, Porton will showcase its end-to-end global CDMO service …

Banner for the 5th Pharma Crystallization Summit, "Debottlenecking Drug Development," held September 26-27, 2024, at Crowne Plaza Princeton, NJ.

Join the 5th Pharma Crystallization Summit: Early Bird Ends Sept 5!

In the pharmaceutical industry, the development of crystallization processes—including for APIs and intermediates, as well as early-stage formulation development—plays a crucial role in the drug development and manufacturing process. Different crystal forms, sizes, and habits can significantly influence the physicochemical …

blank

Porton Passed FDA cGMP Inspection with No Action Indicated(NAI)

On July 16, 2024, Porton Pharma Solutions Ltd. (hereinafter referred to as “Porton”, “the company”, “We”) announced that its Chongqing Changshou Site (CQ2) had undergone a cGMP (current Good Manufacturing Practice) on-site inspection by the U.S. Food and Drug Administration …

Website showing a pharmaceutical research article titled "Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound," published June 13, 2024. Authors listed at the bottom.

Porton and Genentech Publish Breakthrough Crystallization Results

Recently, the crystallization team at Porton and Genentech, Inc. jointly published a paper titled “Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound” in 《Pharmaceutical Research》, the official journal of the American Association of Pharmaceutical Scientists. This journal focuses …

Blue graphic with Porton and University of Perugia logos. Text reads: "Porton Experts Invited to Participate in the University of Perugia Master PRO-API Program.

Porton Experts Join University of Perugia’s Green Chemistry Program

blank

On June 14, 2024, Dr. Francesco Fontana (R&D Director), Dr. Dario Telese (Lead Chemist), and Dr. Lucija Ptiček (Synthesis Laboratory Specialist) from the Porton Slovenian site presented a lecture on the Master PRO-API program of the University of Perugia. The …

Blue background with text: "PORTON J-STAR Collaboration on Co-processing Platform Technology Development" and "Enabling Technologies Consortium" logo. Abstract wave design at bottom.

Porton J-STAR and Consortium Team Up for Co-Processing Technology

blank

June 2024 — Porton J-STAR today announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on “Co-processing Platform Technology.”

The primary goal of co-processing is to improve the reliability and efficiency of drug product …

Banner for BOS Basel 2024 conference, June 19-20 at Congress Center Basel, Switzerland. Features cityscape image and Booth 24 highlighted.

Porton to Join Biotech Outsourcing Strategies Events This June

As the global market for biopharmaceutical research outsourcing continues to flourish, the annual BOS Basel Conference has once again drawn worldwide attention. Since its inception in 2006, the Biotech Outsourcing Strategies (BOS) Events has become a barometer for the research …

Five men stand behind a ceremonial ribbon labeled "PORTON," with balloons and a screen displaying the same text in the background.

Porton Pharma Solutions: Advancing Innovation in Mengeš, Slovenia

On May 22, 2024 the opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients (APIs), small molecules, of the Porton company took place in Mengeš. This marks another milestone of Porton’s globalization journey after the …

Large green letters spelling "CPHI" are displayed in a carpeted lobby area with people walking and sitting in the background.

Porton at CPhI North America again

blank

We’ve had an exciting few days at CPhI North America. We want to express our sincere gratitude to all the present and potential future partners we’ve engaged with. Whether you require assistance with API route scouting, chemistry optimization, or the …